Disease-Modifying Drugs for Adult-Onset Rheumatoid Arthritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Disease-Modifying Drugs for Adult-Onset Rheumatoid Arthritis

Published:2024-03-26 Issue:12 Volume:331 Page:1055
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Faison Maya N.¹,Davis Andrew M.¹,Trotter Kimberly C.²

Affiliation:

1. Section of General Internal Medicine, University of Chicago, Chicago, Illinois

2. Section of Rheumatology, University of Chicago, Chicago, Illinois

Abstract

This article summarizes a 2022 clinical practice guideline on the use of disease-modifying antirheumatic drugs (DMARDs) for adults with rheumatoid arthritis from the European League Against Rheumatism (EULAR).

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jama/articlepdf/2816212/jama_faison_2024_gs_230010_1710443241.21182.pdf

Reference10 articles.

1. Prevalence trend and disparities in rheumatoid arthritis among US adults, 2005-2018.;Xu;J Clin Med,2021

2. Diagnosis and management of rheumatoid arthritis.;Aletaha;JAMA,2018

3. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.;Smolen;Ann Rheum Dis,2023

4. Very early rheumatoid arthritis is the major predictor of major outcomes.;Bosello;Ann Rheum Dis,2011

5. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study).;Grigor;Lancet,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP